Zobrazeno 1 - 10
of 96
pro vyhledávání: '"S I, RAPAPORT"'
Autor:
S I, Rapaport, J, Vermylen, M, Hoylaerts, H, Saito, J, Hirsh, S, Bates, B, Dahlbäck, L, Poller
Publikováno v:
Journal of Thrombosis and Haemostasis. 2:2250-2252
Autor:
L. W. Hoyer, T. Exner, P. Gaffney, H. R. Lijnen, H. Gralnick, J. M. Lusher, H. Saito, P. M. Mannucci, B. Dahlback, C. Kasper, L. Poller, K. J. Clementson, M. Blomback, U Abildgaard, D. Lane, G. J. Johnson, A. M.H.P. Van den Besselaar, C. W. Francis, S. I. Rapaport
Publikováno v:
Thrombosis and Haemostasis. 71:375-394
Publikováno v:
Blood. 77:1256-1262
We have extended our earlier observation that growing primary cultures of human umbilical vein endothelial cells (HUVEC) with heparin binding growth factor 1 (HBGF-1) 20 micrograms/mL and heparin 12 U/mL inhibits expression of tissue factor (TF) acti
Publikováno v:
Blood. 76:354-360
An umbilical vein model was designed in which washed vein segments are filled with a reaction mixture containing factor VIIa, Ca(+)+, and a substrate, either 3H-factor IX or 3H-factor X. The vein wall provides the tissue factor (TF) for factor VIIa/T
Publikováno v:
Blood. 75:1481-1489
Rabbits were given polyclonal anti-tissue factor (TF) immunoglobulin G (IgG) before an injection of endotoxin to test the hypothesis that TF triggers disseminated intravascular coagulation (DIC) after endotoxin. The rabbits had been prepared with cor
Autor:
L V, Rao, S I, Rapaport
Publikováno v:
Blood. 75:1069-1073
Infusing factor VIIa (FVIIa) has been reported to control bleeding in hemophilic patients with factor VIII (FVIII) inhibitors. This is difficult to attribute to an enhanced FVIIa/tissue factor (TF) activation of factor X, since in vitro studies sugge
Publikováno v:
Annals of internal medicine. 126(12)
Despite earlier acceptance of oral vitamin K1 (phytonadione) for the treatment of excessive anticoagulation, some recent guidelines do not recommend its use.To reevaluate the efficacy of oral vitamin K1 in correcting excessive anticoagulation.Case se
Publikováno v:
Thrombosis and haemostasis. 77(3)
The original tissue factor-dependent factor V assay for activated protein C resistant factor Va (Blood 1995; 85: 1704-1711) has been modified to use a calcium containing thromboplastin and to express results as an observed to expected ratio (Obs/Exp.
Publikováno v:
Blood. 87(9)
Experiments were performed to evaluate activation of factor VII bound to relipidated tissue factor (TF) in suspension and to TF constitutively expressed on the surface of an ovarian carcinoma cell line (OC-2008). Activation was assessed by measuring